Santen DRC AVANTE Study (Phase II) - Assess Efficacy, Safety of Intravitreal Injections of DE-122 in combination with Lucentis® Compared to Lucentis® Monotherapy in Subjects with Wet AMD

Administered By

Awarded By

Contributors

Start/End

  • January 1, 2017 - December 31, 2021